Analysis of van der Waals surface area properties for human ether-a-go-go-related gene blocking activity: computational study on structurally diverse compounds

References

• Zhu , BY , Jia , ZJ , Zhang , P , Su , T , Huang , W , Goldman , E , Tumas , D , Kadambi , V , Eddy , P , Sinha , U , Scarborough , RM and Song , Y . 2006 . Inhibitory effect of carboxilic acid group on hERG binding . Bioorg. Med. Chem. Lett. , 16 : 5507 – 5512 .
   PubMed Web of Science ®Google Scholar
• Jamieson , C , Moir , EM , Rankovic , Z and Wishart , G . 2006 . Medicinal chemistry of hERG optimization: Highlights and Hang-ups . J. Med. Chem. , 49 : 5029 – 5049 .
   PubMed Web of Science ®Google Scholar
• Sanguinetti , MC and Mitcheson , JS . 2005 . Predicting drug–hERG channel interactions that cause acquired long QT syndrome . TRENDS Pharmacol. Sci. , 26 : 119 – 124 .
   PubMed Web of Science ®Google Scholar
• Brown , AM . 2004 . Drugs . hERG and sudden death. Cell Calcium , 35 : 543 – 547 .
   PubMed Web of Science ®Google Scholar
• Choe , H , Nah , KH , Lee , SN , Lee , HS , Lee , LS , Jo , SH , Leem , CH and Jang , YJ . 2006 . A novel hypothesis for the binding mode of hERG channel blockers . Biochem. Biophys. Res. Comm. , 344 : 72 – 78 .
   PubMed Web of Science ®Google Scholar
• Perry , M , de Groot , MJ , Helliwell , R , Leishman , D , Tristani-Firouzi , M , Sanguinetti , MC and Mitcheson , J . 2004 . Structural determinants of hERG channel block by Clofilium and Ibutilide . Mol. Pharmacol. , 66 : 240 – 249 .
   PubMed Web of Science ®Google Scholar
• Du , L , Li , M , You , Q and Xia , LA . 2007 . A novel structure-based virtual screening model for the hERG channel blockers . Biochem. Biophys. Res. Comm. , 355 : 889 – 894 .
   PubMed Web of Science ®Google Scholar
• Du , LP , Tsai , KC , Li , MY , You , QD and Xia , L . 2004 . The pharmacophore hypotheses of I(Kr) potassium channel blockers: Novel class III antiarrhythmic agents . Bioorg. Med. Chem. Lett. , 14 : 4771 – 4777 .
   PubMed Web of Science ®Google Scholar
• Cianchetta , G , Li , Y , Kang , J , Rampe , D , Fravolini , A , Cruciani , G and Vaz , RJ . 2005 . Predictive models for hERG potassium channel blockers . Bioorg. Med. Chem. Lett. , 15 : 3637 – 3642 .
   PubMed Web of Science ®Google Scholar
• Yoshida , K and Niwa , T . 2006 . Quantitative structure–activity relationship studies on inhibition of hERG potassium channels . J. Chem. Inf. Model. , 46 : 1371 – 1378 .
   PubMed Web of Science ®Google Scholar
• Seierstad , M and Agrafiotis , DK . 2006 . A QSAR model of hERG binding using a large, diverse, and internally consistent training set . Chem. Biol. Drug Des. , 67 : 284 – 296 .
   PubMed Web of Science ®Google Scholar
• Beshore , DC , Liverton , NJ , McIntyre , CJ , Claiborne , CF , Libby , B , Culberson , JC , Salata , JJ , Regan , CP , Lynch , JJ , Kiss , L , Spencer , R , Kane , SS , White , RB , Yeh , S , Hartman , GD and Dinsmore , CJ . 2010 . Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel . Bioorg. Med. Chem. Lett. , 20 : 2493 – 2496 .
   PubMed Web of Science ®Google Scholar
• Bilodeau , MT , Balitza , AE , Koester , TJ , Manley , PJ , Rodman , LD , Buser-Doepner , C , Coll , KE , Fernandes , C , Gibbs , JB , Heimbrook , DV , Huckle , WR , Kohl , N , Lynch , JJ , Mao , X , McFall , RC , McLoughlin , D , Miller-Stein , C , Rickert , KW , Seep-Lorenzino , L , Shipman , JM , Subramanian , R , Thomas , KA , Wong , BK , Yu , S and Hartman , GD . 2004 . Potent N-(1,3-thiazol-2-yl)pyridine-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for hERG ion channel . J. Med. Chem. , 47 : 6363 – 6372 .
   PubMed Web of Science ®Google Scholar
• Sato , N , Ando , M , Ishikawa , S , Jitsuoka , M , Nagai , K , Takahashi , H , Sakuraba , A , Tsuge , H , Kitazawa , H , Iwassa , H , Mashiko , S , Gomori , A , Moriya , R , Fujino , N , Ohe , T , Ishihara , A , Kanatani , A and Fukami , T . 2009 . Discovery of tetrasubstituted imidazolines as potent and selective neuropeptide Y Y5 receptor antagonists: Reduced human ether-a-go-go related gene potassium channel binding affinity and potent antiobesity effect . J. Med. Chem. , 52 : 3385 – 3396 .
   PubMed Web of Science ®Google Scholar
• Lin , A . QuaSAR-descriptors, J. Chem. Comput. Group. (2002). Available at www.chemcomp.com/journal/descr.htm
   Google Scholar
• Moorthy , NSHN , Ramos , MJ and Fernandes , PA . 2011 . Analysis of α-glucosidase inhibitory activity of chromenone derivatives by its molecular features: A computational study . Med. Chem. , 7 : 526 – 533 .
   PubMed Web of Science ®Google Scholar
• Golbraikh , A and Tropsha , A . 2002 . Beware of Q2 . J. Mol. Graph. Model. , 20 : 269 – 276 .
   PubMed Web of Science ®Google Scholar
• Roy , PP and Roy , K . 2008 . On some aspects of variable selected for partial least squares regression models . QSAR Comb. Sci. , 27 : 302 – 313 .
   Google Scholar
• Moorthy , NSHN , Sousa , SF , Ramos , MJ and Fernandes , PA . 2011 . Structural feature study of benzofuran derivatives as farnesyltransferase inhibitors . J. Enz. Inhibit. Med. Chem. , 26 : 777 – 791 .
   PubMed Web of Science ®Google Scholar
• Kiralj , R and Ferreira , MMC . 2009 . Basic validation procedures for regression models in QSAR and QSPR studies: Theory and applications . J. Braz. Chem. Soc. , 20 : 770 – 787 .
   Web of Science ®Google Scholar
• Guha , R and Van Drie , JH . 2008 . Structure-activity landscape index: Identifying and quantifying activity cliffs . J. Chem. Inf. Model. , 48 : 646 – 658 .
   PubMed Web of Science ®Google Scholar
• Wawer , M , Peltason , L and Bajorath , J . 2009 . Elucidation of structure-activity relationship pathways in biological screening data, J . Med. Chem. , 52 : 1075 – 1080 .
   Web of Science ®Google Scholar
• Peltason , L and Bajorath , J . 2007 . SAR index: Quantifying the nature of structure-activity relationships . J. Med. Chem. , 50 : 5571 – 5578 .
   PubMed Web of Science ®Google Scholar
• Gramatica , P . 2007 . Principle of QSAR model validation: Internal and external . QSAR Comb. Sci. , 26 : 694 – 701 .
   Google Scholar
• Cook , R . 1979 . Dennis, influential observation in linear regression . J. Am. Stat. Assoc. , 74 : 169 – 174 .
   Web of Science ®Google Scholar
• Moorthy , NSHN , Cerquira , NM , Ramos , MJ and Fernandes , PA . QSAR analysis of 2-benzoxazolyl hydrazone derivatives for anticancer activity and its possible target prediction, Med. Chem. Res. 21 (2012), pp. 133–144. DOI: 10.1007/s00044-010-9510-3
   Google Scholar
• Moorthy , NSHN , Ramos , MJ and Fernandes , PA . 2011 . QSAR analysis of isosteviol derivatives as α-glucosidase inhibitors with element count and other descriptors . Lett. Drug Des. Dis. , 8 : 14 – 25 .
   Web of Science ®Google Scholar
• Durbin , J and Watson , GS . 1950 . Testing for serial correlation in least squares regression 1 . Biometrika , 37 : 409 – 428 .
   PubMed Web of Science ®Google Scholar
• Cruciani , C , Crivori , P , Carrupt , PA and Testa , B . 2000 . Molecular fields in quantitative structure-permeation relationships: The VolSurf approach . J. Mol. Struct. (Theochem) , 503 : 17 – 30 .
   Web of Science ®Google Scholar
• Moorthy , NSHN , Ramos , MJ and Fernandes , PA . 2011 . Structural analysis of α-glucosidase inhibitors by validated QSAR models using topological and hydrophobicity based descriptors . J. Chemometr. Intell. Lab. Syst. , 109 : 101 – 112 .
   Web of Science ®Google Scholar
• Cruciani , G , Pastor , M and Guba , W . 2000 . VolSurf, a new tool for the pharmacokinetic optimization of lead compounds . Eur. J. Pharm. Sci. , 11 : S29 – S39 .
   PubMed Web of Science ®Google Scholar
• Moorthy , NSHN , Cerqueira , NMFS , Ramos , MJ and Fernandes , PA . QSAR and pharmacophore analysis of thiosemicarbazone derivatives as ribonucleotide reductase inhibitors, Med. Chem. Res. (2011), DOI: 10.1007/s00044-011-9580-x
   Google Scholar
• Moorthy , NSHN , Sousa , SF , Ramos , MJ and Fernandes , PA . 2011 . In silico based structural analysis of arylthiophene derivatives for FTase inhibitory activity, hERG and other toxic effects4 . J. Biomol. Screen. , 16 : 1037 – 1046 .
   PubMed Web of Science ®Google Scholar
• Moorthy , NSHN , Ramos , MJ and Fernandes , PA . 2011 . hERG binding feature analysis of structurally diverse compounds by QSAR and fragmental analysis . RSC Adv. , 1 : 1126 – 1136 .
   Web of Science ®Google Scholar
• Moorthy , NSHN , Ramos , MJ and Fernandes , PA . Structural analysis of 2-piperidin-4-yl-actamide derivatives for hERG blocking and MCH R1 antagonistic activities, Curr. Drug Dis. Tech. 9 (2012), pp. 25–38
   Google Scholar